Proteasomal insensitivity of apoptin in tumor cells

Biochemical and Biophysical Research Communications

Volumn 422, Issue 1, 2012, Pages 169-173

  Lanz, Henriëtte L ^a   Suijker, Johnny ^a   Noteborn, Mathieu H M ^a   Backendorf, Claude ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Ada Ahx 3L 3VS; Apoptin; Bortezomib; Proteasome; Protein degradation; Tumor selective apoptosis

Indexed keywords

ADA AHX3L3VS; APOPTIN; BORTEZOMIB; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CAPSID PROTEINS; CELL LINE; CELL LINE, TUMOR; FIBROBLASTS; HUMANS; MUTATION; NEOPLASMS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS; PYRAZINES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861456411     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.132     Document Type: Article

References (23)

1. Danen-van Oorschot A.A.A.M., Fischer D.F., Grimbergen J.M., Klein B., Zhuang S., Falkenburg J.H., Backendorf C., Quax P.H., van der Eb A.J., Noteborn M.H.M. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc. Natl. Acad. Sci. USA 1997, 94:5843-5847.
2. Rohn J.L., Zhang Y.-H., Aalbers R.I., Otto N., Den Hertog J., Henriquez N.V., van de Velde C.J., Kuppen P.J., Mumberg D., Donner P., Noteborn M.H.M. A tumor-specific kinase activity regulates the viral death protein apoptin. J. Biol. Chem. 2002, 277:50820-50827.
3. Backendorf C., Visser A.E., de Boer A.G., Zimmerman R.M.E., Visser M., Voskamp P., Zhang Y.-H., Noteborn M.H.M. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu. Rev. Pharmacol. Toxicol. 2008, 48:143-169.
4. Zhang Y.-H., Leliveld S.R., Kooistra K., Molenaar C., Rohn J.L., Tanke H.J., Abrahams J.-P., Noteborn M.H.M. Recombinant apoptin multimers kill tumor cells but are nontoxic and epitope-shielded in normal-cell-specific fashion. Exp. Cell Res. 2003, 289:36-46.
5. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
6. Murata S., Yashiroda H., Tanaka K. Molecular mechanisms of proteasome assembly. Nat. Rev. Mol. Cell Biol. 2009, 10:104-115.
7. Cusack J.C., Liu R., Houston M., Abendroth K., Elliott P.J., Adams J., Baldwin A.S. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-B inhibition. Cancer Res. 2001, 61:3535-3540.
8. Kessler B.M., Tortorella D., Altun M., Kisselev A.F., Fiebiger E., Hekking B.G., Ploegh H.L., Overkleeft H.S. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic β-subunits. Chem. Biol. 2001, 8:913-929.
9. Zimmerman R.M.E., Peng D.-J., Lanz H.L., Zhang Y.-H., Danen-van Oorschot A.A.A.M., Qu S., Backendorf C., Noteborn M.H.M. PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective killing. Cell Death Dis. 2012, 3:e291.
10. Noteborn M.H.M., de Boer G.F., van Roozelaar D.J., Karreman C., Kranenburg O., Vos J.G., Jeurissen S.H.M., Hoeben R.C., Zantema A., Koch G., van Ormondt H., van der Eb A.J. Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J. Virol. 1991, 65:3131-3139.
11. Danen-van Oorschot A.A.A.M., Voskamp P., Seelen M., van Miltenburg M., Bolk M., Tait S., Boesen-de Cock J., Rohn J., Borst J., Noteborn M.H.M. Human death effector domain-associated factor interacts with the viral apoptosis agonist apoptin and exerts tumor-preferential cell killing. Cell Death Dif. 2004, 11:564-573.
12. Florea B.I., Verdoes M., Li N., van der Linden W.A., Geurink P.P., van den Elst H., Hofmann T., de Ru A., van Veelen P.A., Tanaka K., Sasaki K., Murata S., den Dulk H., Brouwer J., Ossendorp F.A., Kisselev A.F., Overkleeft H.S. Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t. Chem. Biol. 2010, 17:795-801.
13. Kisselev A.F., Callard A., Goldberg A.L. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J. Biol. Chem. 2006, 281:8582-8590.
14. Rohn J.L., Zhang Y.-H., Leliveld S.R., Danen-van Oorschot A.A.A.M., Henriquez N.V., Abrahams J.-P., Noteborn N.H.M. Relevance of apoptin's integrity for its functional behaviour. J. Virol. 2005, 79:1337-1338.
15. Diller L., Kassel J., Nelson C.E., Gryka M.A., Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker S.J., Vogelstein B. P53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell Biol. 1990, 10:5772-5781.
16. Zhuang S.M., Shvarts A., van Ormondt H., Jochemsen A.G., van der Eb A.J., Noteborn M.H.M. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res. 1995, 55:486-489.
17. Yuan J., Luo K., Zhang L., Cheville J.C., Lou Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 2010, 140:384-396.
18. Hoeller D., Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009, 458:438-444.
19. Bousquet-Dubouch M.P., Fabre B., Monsarrat B., Burlet-Schiltz O. Proteomics to study the diversity and dynamics of proteasome complexes: from fundamentals to the clinic. Expert Rev. Proteomics 2011, 8:459-481.
20. Hu Z., Zhang Z., Doo E., Coux O., Goldberg A.L., Liang T.J. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 1999, 73:7231-7240.
21. Garcia-Higuera I., Manchado E., Dubus P., Canamero M., Mendez J., Moreno S., Malumbres M. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat. Cell Biol. 2008, 10:802-811.
22. Smolders L., Teodoro J.G. Targeting the anaphase promoting complex: common pathways for viral infection and cancer therapy. Expert Opin. Ther. Targets 2011, 15:767-780.
23. Teodoro J.G., Heilman D.W., Parker A.E., Green M.R. The viral protein apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev. 2004, 18:1952-1957.